Industry Research Reports
Home > Reports > Chemical & Material > Hirudin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Hirudin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Industry: Chemical & Material
Published Date: 2026-01-04
Pages: 138 Pages
Report ld: 5498756
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Hirudin Market Size(US$)
CAGR 2026-2032
3.1%
Market Size,2032
USD 5,359
Million
Market Snapshot
Market Size in 2026 (Value)
US$ 4,462 million
Market Forecast in 2032(Value)
US$ 5,359 million
CAGR
3.1%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Hirudin was estimated to be worth US$ 4341 million in 2025 and is projected to reach US$ 5359 million, growing at a CAGR of 3.1% from 2026 to 2032.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Hirudin cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Hirudin is a potent anticoagulant protein originally derived from the salivary glands of the medicinal leech (Hirudo medicinalis). Its mechanism of action involves directly binding to thrombin, the enzyme responsible for converting fibrinogen into fibrin during the clotting process, thus preventing blood coagulation. This unique property makes hirudin a highly effective anticoagulant, especially in patients at risk of thrombus formation. With the advancement of biotechnology, the production of hirudin has shifted from being sourced directly from leeches to large-scale synthesis through recombinant DNA technology in laboratories. Currently, hirudin is primarily used in the treatment of thrombotic conditions such as deep vein thrombosis (DVT), pulmonary embolism, and certain types of strokes. It is considered an effective alternative for patients who are allergic or intolerant to traditional anticoagulants like heparin. Over the years, with increasing research into hirudin’s applications, various derivatives and related drugs, such as lepirudin and desirudin, have been developed, broadening its clinical use.
The market development of hirudin is driven by several factors. Firstly, the growing global demand for the treatment of thrombotic diseases, particularly among cardiovascular patients and post-surgical individuals, presents significant opportunities for hirudin and its derivatives. With the aging population and the increasing prevalence of thrombotic and vascular diseases, there is a rising demand for effective anticoagulants. Secondly, hirudin's unique mechanism of action offers advantages in treating certain conditions, particularly for patients who are allergic to traditional anticoagulants like heparin, further driving the market for hirudin products.
However, the hirudin market faces challenges and risks. The production cost remains high, particularly in the early stages when biotechnology was not fully developed, limiting its widespread use. Additionally, although hirudin has strong anticoagulant effects, its use requires careful monitoring of the patient's coagulation function to prevent the risk of bleeding.
In terms of market concentration, as production technologies for hirudin mature, the market has become more concentrated in the hands of a few large pharmaceutical companies that maintain their market share through acquisitions, research and development, and patented technologies. The downstream demand trend is diversifying, with hirudin finding applications not only in traditional thrombotic disease treatment but also in other coagulation disorders and post-surgical care. Recent technological advances include the recombinant production of hirudin using genetic engineering, which has significantly improved production efficiency and lowered costs, potentially expanding the use of hirudin in the future.
This report provides a comprehensive view of the global market for Hirudin, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Hirudin market size, estimations, and forecasts are presented in terms of sales volume (Tons) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Hirudin.
MARKET SEGMENTATION
By Company
- Novartis
- Teva Pharmaceuticals
- Pfizer, Inc
- Pentapharm
- DUOPUTAI
- Abbott
- Keyken
- Minapharm
- Salubris Bio
- Hoechst AG
- Ciba-Geigy
- Boehringer Ingelheim
- Sanofi
- Xellia Pharmaceuticals
- Haplogen Pharmaceuticals
- Shenzhen Kangtai Biological
- Dong-A ST
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Natural Hirudin
- Recombinant Hirudin
Segment by Application
- Thrombosis Disease
- Tumor Disease
- Others
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Hirudin manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Hirudin sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Hirudin sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Hirudin Product Introduction
1.2 Global Hirudin Market Size Forecast
1.2.1 Global Hirudin Sales Value (2021–2032)
1.2.2 Global Hirudin Sales Volume (2021–2032)
1.2.3 Global Hirudin Sales Price (2021–2032)
1.3 Hirudin Market Trends & Drivers
1.3.1 Hirudin Industry Trends
1.3.2 Hirudin Market Drivers & Opportunities
1.3.3 Hirudin Market Challenges
1.3.4 Hirudin Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Hirudin Players Revenue Ranking (2025)
2.2 Global Hirudin Revenue by Company (2021–2026)
2.3 Global Hirudin Sales Volume Ranking of Players (2025)
2.4 Global Hirudin Sales Volume by Company (2021–2026)
2.5 Global Hirudin Average Price by Company (2021–2026)
2.6 Key Manufacturers Hirudin Manufacturing Base and Headquarters
2.7 Key Manufacturers Hirudin Product Offerings
2.8 Key Manufacturers Start of Mass Production of Hirudin
2.9 Hirudin Market Competitive Analysis
2.9.1 Hirudin Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Hirudin Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Hirudin revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Hirudin Market Classification
3.1 Introduction by Type
3.1.1 Natural Hirudin
3.1.2 Recombinant Hirudin
3.1.3 Global Hirudin Sales Value by Type
3.1.3.1 Global Hirudin Sales Value by Type (2021 vs 2025 vs 2032)
3.1.3.2 Global Hirudin Sales Value, by Type (2021–2032)
3.1.3.3 Global Hirudin Sales Value, by Type (%), 2021–2032
3.1.4 Global Hirudin Sales Volume by Type
3.1.4.1 Global Hirudin Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.4.2 Global Hirudin Sales Volume, by Type (2021–2032)
3.1.4.3 Global Hirudin Sales Volume, by Type (%), 2021–2032
3.1.5 Global Hirudin Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Thrombosis Disease
4.1.2 Tumor Disease
4.1.3 Others
4.2 Global Hirudin Sales Value by Application
4.2.1 Global Hirudin Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Hirudin Sales Value, by Application (2021–2032)
4.2.3 Global Hirudin Sales Value, by Application (%), 2021–2032
4.3 Global Hirudin Sales Volume by Application
4.3.1 Global Hirudin Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Hirudin Sales Volume, by Application (2021–2032)
4.3.3 Global Hirudin Sales Volume, by Application (%), 2021–2032
4.4 Global Hirudin Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Hirudin Sales Value by Region
5.1.1 Global Hirudin Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Hirudin Sales Value by Region (2021–2026)
5.1.3 Global Hirudin Sales Value by Region (2027–2032)
5.1.4 Global Hirudin Sales Value by Region (%), 2021–2032
5.2 Global Hirudin Sales Volume by Region
5.2.1 Global Hirudin Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Hirudin Sales Volume by Region (2021–2026)
5.2.3 Global Hirudin Sales Volume by Region (2027–2032)
5.2.4 Global Hirudin Sales Volume by Region (%), 2021–2032
5.3 Global Hirudin Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Hirudin Sales Value, 2021–2032
5.4.2 North America Hirudin Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Hirudin Sales Value, 2021–2032
5.5.2 Europe Hirudin Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Hirudin Sales Value, 2021–2032
5.6.2 Asia Pacific Hirudin Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Hirudin Sales Value, 2021–2032
5.7.2 South America Hirudin Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Hirudin Sales Value, 2021–2032
5.8.2 Middle East & Africa Hirudin Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Hirudin Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Hirudin Sales Value and Sales Volume
6.2.1 Key Countries/Regions Hirudin Sales Value, 2021–2032
6.2.2 Key Countries/Regions Hirudin Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Hirudin Sales Value, 2021–2032
6.3.2 United States Hirudin Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Hirudin Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Hirudin Sales Value, 2021–2032
6.4.2 Europe Hirudin Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Hirudin Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Hirudin Sales Value, 2021–2032
6.5.2 China Hirudin Sales Value by Type (%), 2025 vs 2032
6.5.3 China Hirudin Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Hirudin Sales Value, 2021–2032
6.6.2 Japan Hirudin Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Hirudin Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Hirudin Sales Value, 2021–2032
6.7.2 South Korea Hirudin Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Hirudin Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Hirudin Sales Value, 2021–2032
6.8.2 Southeast Asia Hirudin Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Hirudin Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Hirudin Sales Value, 2021–2032
6.9.2 India Hirudin Sales Value by Type (%), 2025 vs 2032
6.9.3 India Hirudin Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Novartis
7.1.1 Novartis Company Information
7.1.2 Novartis Introduction and Business Overview
7.1.3 Novartis Hirudin Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 Novartis Hirudin Product Offerings
7.1.5 Novartis Recent Developments
7.2 Teva Pharmaceuticals
7.2.1 Teva Pharmaceuticals Company Information
7.2.2 Teva Pharmaceuticals Introduction and Business Overview
7.2.3 Teva Pharmaceuticals Hirudin Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 Teva Pharmaceuticals Hirudin Product Offerings
7.2.5 Teva Pharmaceuticals Recent Developments
7.3 Pfizer, Inc
7.3.1 Pfizer, Inc Company Information
7.3.2 Pfizer, Inc Introduction and Business Overview
7.3.3 Pfizer, Inc Hirudin Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 Pfizer, Inc Hirudin Product Offerings
7.3.5 Pfizer, Inc Recent Developments
7.4 Pentapharm
7.4.1 Pentapharm Company Information
7.4.2 Pentapharm Introduction and Business Overview
7.4.3 Pentapharm Hirudin Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 Pentapharm Hirudin Product Offerings
7.4.5 Pentapharm Recent Developments
7.5 DUOPUTAI
7.5.1 DUOPUTAI Company Information
7.5.2 DUOPUTAI Introduction and Business Overview
7.5.3 DUOPUTAI Hirudin Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 DUOPUTAI Hirudin Product Offerings
7.5.5 DUOPUTAI Recent Developments
7.6 Abbott
7.6.1 Abbott Company Information
7.6.2 Abbott Introduction and Business Overview
7.6.3 Abbott Hirudin Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 Abbott Hirudin Product Offerings
7.6.5 Abbott Recent Developments
7.7 Keyken
7.7.1 Keyken Company Information
7.7.2 Keyken Introduction and Business Overview
7.7.3 Keyken Hirudin Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 Keyken Hirudin Product Offerings
7.7.5 Keyken Recent Developments
7.8 Minapharm
7.8.1 Minapharm Company Information
7.8.2 Minapharm Introduction and Business Overview
7.8.3 Minapharm Hirudin Sales, Revenue, Price and Gross Margin (2021–2026)
7.8.4 Minapharm Hirudin Product Offerings
7.8.5 Minapharm Recent Developments
7.9 Salubris Bio
7.9.1 Salubris Bio Company Information
7.9.2 Salubris Bio Introduction and Business Overview
7.9.3 Salubris Bio Hirudin Sales, Revenue, Price and Gross Margin (2021–2026)
7.9.4 Salubris Bio Hirudin Product Offerings
7.9.5 Salubris Bio Recent Developments
7.10 Hoechst AG
7.10.1 Hoechst AG Company Information
7.10.2 Hoechst AG Introduction and Business Overview
7.10.3 Hoechst AG Hirudin Sales, Revenue, Price and Gross Margin (2021–2026)
7.10.4 Hoechst AG Hirudin Product Offerings
7.10.5 Hoechst AG Recent Developments
7.11 Ciba-Geigy
7.11.1 Ciba-Geigy Company Information
7.11.2 Ciba-Geigy Introduction and Business Overview
7.11.3 Ciba-Geigy Hirudin Sales, Revenue, Price and Gross Margin (2021–2026)
7.11.4 Ciba-Geigy Hirudin Product Offerings
7.11.5 Ciba-Geigy Recent Developments
7.12 Boehringer Ingelheim
7.12.1 Boehringer Ingelheim Company Information
7.12.2 Boehringer Ingelheim Introduction and Business Overview
7.12.3 Boehringer Ingelheim Hirudin Sales, Revenue, Price and Gross Margin (2021–2026)
7.12.4 Boehringer Ingelheim Hirudin Product Offerings
7.12.5 Boehringer Ingelheim Recent Developments
7.13 Sanofi
7.13.1 Sanofi Company Information
7.13.2 Sanofi Introduction and Business Overview
7.13.3 Sanofi Hirudin Sales, Revenue, Price and Gross Margin (2021–2026)
7.13.4 Sanofi Hirudin Product Offerings
7.13.5 Sanofi Recent Developments
7.14 Xellia Pharmaceuticals
7.14.1 Xellia Pharmaceuticals Company Information
7.14.2 Xellia Pharmaceuticals Introduction and Business Overview
7.14.3 Xellia Pharmaceuticals Hirudin Sales, Revenue, Price and Gross Margin (2021–2026)
7.14.4 Xellia Pharmaceuticals Hirudin Product Offerings
7.14.5 Xellia Pharmaceuticals Recent Developments
7.15 Haplogen Pharmaceuticals
7.15.1 Haplogen Pharmaceuticals Company Information
7.15.2 Haplogen Pharmaceuticals Introduction and Business Overview
7.15.3 Haplogen Pharmaceuticals Hirudin Sales, Revenue, Price and Gross Margin (2021–2026)
7.15.4 Haplogen Pharmaceuticals Hirudin Product Offerings
7.15.5 Haplogen Pharmaceuticals Recent Developments
7.16 Shenzhen Kangtai Biological
7.16.1 Shenzhen Kangtai Biological Company Information
7.16.2 Shenzhen Kangtai Biological Introduction and Business Overview
7.16.3 Shenzhen Kangtai Biological Hirudin Sales, Revenue, Price and Gross Margin (2021–2026)
7.16.4 Shenzhen Kangtai Biological Hirudin Product Offerings
7.16.5 Shenzhen Kangtai Biological Recent Developments
7.17 Dong-A ST
7.17.1 Dong-A ST Company Information
7.17.2 Dong-A ST Introduction and Business Overview
7.17.3 Dong-A ST Hirudin Sales, Revenue, Price and Gross Margin (2021–2026)
7.17.4 Dong-A ST Hirudin Product Offerings
7.17.5 Dong-A ST Recent Developments
8 Industry Chain Analysis
8.1 Hirudin Industrial Chain
8.2 Hirudin Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Hirudin Sales Model
8.5.2 Sales Channels
8.5.3 Hirudin Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Hirudin Market Trends
Table 2. Hirudin Market Drivers & Opportunities
Table 3. Hirudin Market Challenges
Table 4. Hirudin Market Restraints
List of Figures
Figure 1. Hirudin Product Picture
Figure 2. Global Hirudin Sales Value, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Global Hirudin Sales Value (US$ Million), 2021–2032
Figure 4. Global Hirudin Sales Volume (Tons), 2021–2032
Figure 5. Global Hirudin Sales Price (US$/kg), 2021–2032
Figure 6. Hirudin Report Years Considered
Figure 7. Global Hirudin Players Revenue Ranking (US$ Million), 2025
Figure 8. Global Hirudin Sales Volume Ranking of Players (Tons), 2025
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Hirudin Revenue in 2025
Figure 10. Hirudin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 11. Natural Hirudin Picture
Figure 12. Recombinant Hirudin Picture
Figure 13. Global Hirudin Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Hirudin Sales Value Market Share by Type, 2025 & 2032
Figure 15. Global Hirudin Sales Volume by Type (Tons), 2021 vs 2025 vs 2032
Figure 16. Global Hirudin Sales Volume Market Share by Type, 2025 & 2032
Figure 17. Global Hirudin Price by Type (US$/kg), 2021–2032
Figure 18. Product Picture of Thrombosis Disease
Figure 19. Product Picture of Tumor Disease
Figure 20. Product Picture of Others
Figure 21. Global Hirudin Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032
Figure 22. Global Hirudin Sales Value Market Share by Application, 2025 & 2032
Figure 23. Global Hirudin Sales Volume by Application (Tons), 2021 vs 2025 vs 2032
Figure 24. Global Hirudin Sales Volume Market Share by Application, 2025 & 2032
Figure 25. Global Hirudin Price by Application (US$/kg), 2021–2032
Figure 26. North America Hirudin Sales Value (US$ Million), 2021–2032
Figure 27. North America Hirudin Sales Value by Country (%), 2025 vs 2032
Figure 28. Europe Hirudin Sales Value (US$ Million), 2021–2032
Figure 29. Europe Hirudin Sales Value by Country (%), 2025 vs 2032
Figure 30. Asia Pacific Hirudin Sales Value (US$ Million), 2021–2032
Figure 31. Asia Pacific Hirudin Sales Value by Region (%), 2025 vs 2032
Figure 32. South America Hirudin Sales Value (US$ Million), 2021–2032
Figure 33. South America Hirudin Sales Value by Country (%), 2025 vs 2032
Figure 34. Middle East & Africa Hirudin Sales Value (US$ Million), 2021–2032
Figure 35. Middle East & Africa Hirudin Sales Value by Country (%), 2025 vs 2032
Figure 36. Key Countries/Regions Hirudin Sales Value (%), 2021–2032
Figure 37. Key Countries/Regions Hirudin Sales Volume (%), 2021–2032
Figure 38. United States Hirudin Sales Value (US$ Million), 2021–2032
Figure 39. United States Hirudin Sales Value by Type (%), 2025 vs 2032
Figure 40. United States Hirudin Sales Value by Application (%), 2025 vs 2032
Figure 41. Europe Hirudin Sales Value (US$ Million), 2021–2032
Figure 42. Europe Hirudin Sales Value by Type (%), 2025 vs 2032
Figure 43. Europe Hirudin Sales Value by Application (%), 2025 vs 2032
Figure 44. China Hirudin Sales Value (US$ Million), 2021–2032
Figure 45. China Hirudin Sales Value by Type (%), 2025 vs 2032
Figure 46. China Hirudin Sales Value by Application (%), 2025 vs 2032
Figure 47. Japan Hirudin Sales Value (US$ Million), 2021–2032
Figure 48. Japan Hirudin Sales Value by Type (%), 2025 vs 2032
Figure 49. Japan Hirudin Sales Value by Application (%), 2025 vs 2032
Figure 50. South Korea Hirudin Sales Value (US$ Million), 2021–2032
Figure 51. South Korea Hirudin Sales Value by Type (%), 2025 vs 2032
Figure 52. South Korea Hirudin Sales Value by Application (%), 2025 vs 2032
Figure 53. Southeast Asia Hirudin Sales Value (US$ Million), 2021–2032
Figure 54. Southeast Asia Hirudin Sales Value by Type (%), 2025 vs 2032
Figure 55. Southeast Asia Hirudin Sales Value by Application (%), 2025 vs 2032
Figure 56. India Hirudin Sales Value (US$ Million), 2021–2032
Figure 57. India Hirudin Sales Value by Type (%), 2025 vs 2032
Figure 58. India Hirudin Sales Value by Application (%), 2025 vs 2032
Figure 59. Hirudin Industrial Chain
Figure 60. Hirudin Manufacturing Cost Structure
Figure 61. Channels of Distribution (Direct Sales, and Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What is the annual compound growth rate of the global Hirudin market size from 2026 to 2032?
The annual compound growth rate of the global Hirudin market is 3.1% 2026 to 2032.
What was the global market size of Hirudin in 2026?
Which companies rank high in the global Hirudin market?
What was the global market size of Hirudin in 2032?
Which region is expected to have the highest market share?
Related Reports
Global Hirudin Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Hirudin market size was US$ 4341 million in 2025 and is forecast to reach a readjusted size of US$ 5359 million by 2032 with a CAGR of 3.1% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 107
USD 4250.00
(Single User License)
Global Hirudin Market Research Report 2026
The global Hirudin market was valued at US$ 4341 million in 2025 and is anticipated to reach US$ 5359 million by 2032, at a CAGR of 3.1% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 150
USD 2900.00
(Single User License)
Global Hirudin Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Hirudin market is projected to grow from US$ 4223 million in 2024 to US$ 5214 million by 2031, at a CAGR of 3.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 180
USD 4900.00
(Single User License)
Hirudin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hirudin was estimated to be worth US$ 4223 million in 2024 and is forecast to a readjusted size of US$ 5214 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published Date: 2025-06-11
Pages: 142
USD 3950.00
(Single User License)
Global Hirudin Market Insights, Forecast to 2031
The global Hirudin market is projected to grow from US$ 4341 million in 2025 to US$ 5214 million by 2031, at a Compound Annual Growth Rate (CAGR) of 3.1% during the forecast period.
Published Date: 2025-06-11
Pages: 180
USD 4900.00
(Single User License)
Global Hirudin Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Hirudin market size was US$ 4223 million in 2024 and is forecast to a readjusted size of US$ 5214 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published Date: 2025-06-11
Pages: 106
USD 4250.00
(Single User License)
Global Hirudin Market Research Report 2025
The global market for Hirudin was valued at US$ 4223 million in the year 2024 and is projected to reach a revised size of US$ 5214 million by 2031, growing at a CAGR of 3.1% during the forecast period.
Published Date: 2025-06-11
Pages: 114
USD 2900.00
(Single User License)
Global Hirudin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Hirudin was estimated to be worth US$ 4223 million and is forecast to reach approximately US$ 5214 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 139
USD 5900.00
(Single User License)
Hirudin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hirudin was estimated to be worth US$ 4223 million in 2024 and is forecast to a readjusted size of US$ 5214 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 97
USD 3950.00
(Single User License)
Global Hirudin Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
This report studies the Hirudin market. Hirudin is a naturally occurring peptide in the salivary glands of medicinal leeches (such as Hirudo medicinalis) that has a blood anticoagulant property. Hirudin is the most potent natural inhibitor of thrombin. Hirudin (hirudin) is a Leech (Leech) and salivary glands have been extracted from a variety of active ingredients in the activity of the most significant and most studied ingredients, which is 65-66 amino acids from the small molecules of protein (peptide) . Hirudin have strong inhibitory effect on thrombin is the strongest so far found in the natural specific inhibitor of thrombin. Animal experiments and clinical studies have shown that hirudin can be effective anticoagulant, antithrombotic, and prevent thrombin-catalyzed activation of coagulation factors and platelet reactions and blood stasis phenomenon further. In addition, it also inhibited thrombin-induced fibroblast proliferation, and thrombin stimulation of endothelial cells. Compared with heparin, which not only use less, do not cause bleeding, is not dependent on endogenous cofactor; and heparin have caused the risk of bleeding, disseminated intravascular coagulation in the pathogenesis of antithrombin III are reduced This will limit the efficacy of heparin, using leeches will have good results.
Published Date: 2024-04-17
Pages: 154
USD 5600.00
(Single User License)
Global Hirudin Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Hirudin market size was US$ 4341 million in 2025 and is forecast to reach a readjusted size of US$ 5359 million by 2032 with a CAGR of 3.1% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 107
USD 4250.00 (Single User License)Global Hirudin Market Research Report 2026
The global Hirudin market was valued at US$ 4341 million in 2025 and is anticipated to reach US$ 5359 million by 2032, at a CAGR of 3.1% from 2026 to 2032.
Published: 2026-01-04
Pages: 150
USD 2900.00 (Single User License)Global Hirudin Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Hirudin market is projected to grow from US$ 4223 million in 2024 to US$ 5214 million by 2031, at a CAGR of 3.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 180
USD 4900.00 (Single User License)Hirudin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hirudin was estimated to be worth US$ 4223 million in 2024 and is forecast to a readjusted size of US$ 5214 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published: 2025-06-11
Pages: 142
USD 3950.00 (Single User License)Global Hirudin Market Insights, Forecast to 2031
The global Hirudin market is projected to grow from US$ 4341 million in 2025 to US$ 5214 million by 2031, at a Compound Annual Growth Rate (CAGR) of 3.1% during the forecast period.
Published: 2025-06-11
Pages: 180
USD 4900.00 (Single User License)Global Hirudin Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Hirudin market size was US$ 4223 million in 2024 and is forecast to a readjusted size of US$ 5214 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published: 2025-06-11
Pages: 106
USD 4250.00 (Single User License)Global Hirudin Market Research Report 2025
The global market for Hirudin was valued at US$ 4223 million in the year 2024 and is projected to reach a revised size of US$ 5214 million by 2031, growing at a CAGR of 3.1% during the forecast period.
Published: 2025-06-11
Pages: 114
USD 2900.00 (Single User License)Global Hirudin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Hirudin was estimated to be worth US$ 4223 million and is forecast to reach approximately US$ 5214 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 139
USD 5900.00 (Single User License)Hirudin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hirudin was estimated to be worth US$ 4223 million in 2024 and is forecast to a readjusted size of US$ 5214 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 97
USD 3950.00 (Single User License)Global Hirudin Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
This report studies the Hirudin market. Hirudin is a naturally occurring peptide in the salivary glands of medicinal leeches (such as Hirudo medicinalis) that has a blood anticoagulant property. Hirudin is the most potent natural inhibitor of thrombin. Hirudin (hirudin) is a Leech (Leech) and salivary glands have been extracted from a variety of active ingredients in the activity of the most significant and most studied ingredients, which is 65-66 amino acids from the small molecules of protein (peptide) . Hirudin have strong inhibitory effect on thrombin is the strongest so far found in the natural specific inhibitor of thrombin. Animal experiments and clinical studies have shown that hirudin can be effective anticoagulant, antithrombotic, and prevent thrombin-catalyzed activation of coagulation factors and platelet reactions and blood stasis phenomenon further. In addition, it also inhibited thrombin-induced fibroblast proliferation, and thrombin stimulation of endothelial cells. Compared with heparin, which not only use less, do not cause bleeding, is not dependent on endogenous cofactor; and heparin have caused the risk of bleeding, disseminated intravascular coagulation in the pathogenesis of antithrombin III are reduced This will limit the efficacy of heparin, using leeches will have good results.
Published: 2024-04-17
Pages: 154
USD 5600.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now